SPDR S&P Pharmaceuticals ETF (XPH)
Seasonality Analysis
SPDR S&P Pharmaceuticals ETF Annual Seasonality Statistics
SPDR S&P Pharmaceuticals ETF Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | 0.44% | Moderate | |
| February | -0.32% | Weak | |
| March | -0.97% | Weak | |
| April | 1.25% | Moderate | |
| May | 0.83% | Moderate | |
| June | 1.07% | Moderate | |
| July | 1.09% | Moderate | |
| August | 0.99% | Moderate | |
| September WORST | -1.37% | Weak | |
| October | -0.33% | Weak | |
| November BEST | 2.40% | Strong | |
| December | 1.04% | Moderate |
SPDR S&P Pharmaceuticals ETF 2026 vs Historical Pattern
SPDR S&P Pharmaceuticals ETF Interactive Seasonality Chart
SPDR S&P Pharmaceuticals ETF Pattern Scanner
SPDR S&P Pharmaceuticals ETF Seasonal Historical Performance
About SPDR S&P Pharmaceuticals ETF (XPH) Seasonality
SPDR S&P Pharmaceuticals ETF (XPH) has been analyzed using 20 years of historical data to identify seasonal patterns. Classified under ETFs, SPDR S&P Pharmaceuticals ETF shows distinct seasonal tendencies based on historical data.
The strongest month for SPDR S&P Pharmaceuticals ETF is historically November, with an average return of 2.40% and a win rate of 65%. Conversely, September tends to be the weakest month, averaging -1.37% return.
Looking at the full calendar year, SPDR S&P Pharmaceuticals ETF has an average annual return of 6.12% with an overall monthly win rate of 57.4%. Out of 12 months, 8 typically show positive average returns.
The seasonal pattern for SPDR S&P Pharmaceuticals ETF has a consistency score of 43.3 (Poor), based on 21 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
SPDR S&P Pharmaceuticals ETF Seasonality FAQ
What is the best month to buy SPDR S&P Pharmaceuticals ETF (XPH)?
Historically, November has been the best month for SPDR S&P Pharmaceuticals ETF, with an average return of 2.40% and a win rate of 65%. However, past performance does not guarantee future results.
What is the worst month for SPDR S&P Pharmaceuticals ETF (XPH)?
Based on historical data, September has been the weakest month for SPDR S&P Pharmaceuticals ETF, with an average return of -1.37%. This is a historical observation and does not guarantee future results.
How reliable is XPH seasonality data?
The seasonality analysis for SPDR S&P Pharmaceuticals ETF is based on 20 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use SPDR S&P Pharmaceuticals ETF seasonality in my trading?
Use SPDR S&P Pharmaceuticals ETF (XPH) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.